Molina Healthcare (NYSE:MOH) – Stock analysts at Leerink Swann decreased their Q1 2018 EPS estimates for Molina Healthcare in a report released on Monday, April 16th. Leerink Swann analyst A. Gupte now expects that the company will post earnings per share of $0.85 for the quarter, down from their previous forecast of $0.93. Leerink Swann currently has a “Outperform” rating and a $110.00 target price on the stock. Leerink Swann also issued estimates for Molina Healthcare’s Q2 2018 earnings at $1.02 EPS, Q3 2018 earnings at $1.14 EPS, Q4 2018 earnings at $1.09 EPS and FY2021 earnings at $5.96 EPS.

How to Become a New Pot Stock Millionaire

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Monday, February 12th. The company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.11. Molina Healthcare had a positive return on equity of 17.64% and a negative net margin of 2.58%. The business had revenue of $4.95 billion for the quarter, compared to the consensus estimate of $4.96 billion.

Other research analysts also recently issued research reports about the company. Jefferies Group reiterated a “hold” rating and issued a $80.00 price objective on shares of Molina Healthcare in a report on Wednesday, February 14th. BMO Capital Markets dropped their price objective on Molina Healthcare from $98.00 to $85.00 and set a “market perform” rating on the stock in a report on Wednesday, February 14th. Zacks Investment Research downgraded Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 9th. Morgan Stanley dropped their price target on Molina Healthcare from $97.00 to $94.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 7th. Finally, Piper Jaffray raised their price target on Molina Healthcare to $92.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 20th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company. Molina Healthcare has an average rating of “Hold” and an average price target of $78.86.

MOH opened at $83.13 on Tuesday. Molina Healthcare has a one year low of $47.07 and a one year high of $93.98. The stock has a market capitalization of $4,864.17, a PE ratio of 27.80, a price-to-earnings-growth ratio of 1.44 and a beta of 1.20. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.13.

Several hedge funds have recently made changes to their positions in MOH. Iridian Asset Management LLC CT purchased a new position in shares of Molina Healthcare in the 4th quarter valued at approximately $128,179,000. Southpoint Capital Advisors LP purchased a new position in shares of Molina Healthcare in the 4th quarter valued at approximately $60,577,000. Renaissance Technologies LLC grew its stake in shares of Molina Healthcare by 53.5% in the 4th quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock valued at $165,334,000 after purchasing an additional 751,800 shares during the last quarter. Victory Capital Management Inc. grew its stake in shares of Molina Healthcare by 36.0% in the 4th quarter. Victory Capital Management Inc. now owns 1,590,409 shares of the company’s stock valued at $121,953,000 after purchasing an additional 420,756 shares during the last quarter. Finally, TCW Group Inc. purchased a new position in shares of Molina Healthcare in the 4th quarter valued at approximately $30,407,000.

In other Molina Healthcare news, Director John C. Molina sold 62,420 shares of Molina Healthcare stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $72.13, for a total value of $4,502,354.60. Following the transaction, the director now directly owns 393,410 shares in the company, valued at approximately $28,376,663.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Steven J. Orlando sold 1,500 shares of Molina Healthcare stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $72.77, for a total value of $109,155.00. The disclosure for this sale can be found here. Insiders sold a total of 230,974 shares of company stock worth $19,392,787 over the last quarter. Company insiders own 0.65% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Molina Healthcare Expected to Earn Q1 2018 Earnings of $0.85 Per Share (MOH)” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2018/04/17/molina-healthcare-expected-to-earn-q1-2018-earnings-of-0-85-per-share-moh.html.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.